WCN24-162 ASSOCIATION BETWEEN HUMAN LEUKOCYTE ANTIGENS AND END STAGE KIDNEY DISEASE IN A SAMPLE OF IRAQI POPULATION

WCN24-162 ASSOCIATION BETWEEN HUMAN LEUKOCYTE ANTIGENS AND END STAGE KIDNEY DISEASE IN A SAMPLE OF IRAQI POPULATION

Saved in:

Bibliographic Details
Main Authors:	ALA Ali, Haider Al-Ibrahemey H., Riyadh Al-Saegh M.
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924005680
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN25-2419 COMPLEMENT COMPONENT 4d(C4d) DEPOSITION AND PROGNOSIS IN LUPUS NEPHRITIS
by: Riyadh Al-Saegh, et al.
Published: (2025-02-01)

WCN25-151 Perception of Nephrology Practice and Attitude in a sample of Iraqi medical Specialists
by: Ala Ali, et al.
Published: (2025-02-01)

WCN24-343 DECISION-MAKING IN PERSONS WITH END STAGE KIDNEY DISEASE
by: Unini Odama
Published: (2024-04-01)

Investigation the role of Human Leukocyte Antigen-G in Iraqi patients with papillary thyroid carcinoma
by: Noor H. Aljanabi, et al.
Published: (2024-06-01)

Frequency of HLA Antigens in a Sample of Iraqi Brucellosis Patients
by: Baghdad Science Journal
Published: (2012-03-01)

Leukocyte Dysregulation and Biochemical Alterations in End-Stage Kidney Disease Patients Under Hemodialysis
by: Gabriela Goyoneche Linares, et al.
Published: (2025-03-01)

WCN24-1141 EVALUATION OF RESPONSES OF KIDNEY HEALTHCARE PROVIDERS DECISION-MAKING PROCESSES OF END STAGE KIDNEY DISEASE PATIENTS
by: Rumeyza Kazancioglu, et al.
Published: (2024-04-01)

WCN25-405 eGFR Trajectories in Iraqi Cancer Patients at First Presentation
by: Ala Ali, et al.
Published: (2025-02-01)

WCN24-638 LUMINAL IMMUNE SURVEILLANCE OF FILTERED ANTIGENS: IMPLICATIONS FOR ADAPTIVE IMMUNE RESPONSES IN THE KIDNEY
by: Esteban Elias, et al.
Published: (2024-04-01)

WCN24-1898 HEMODIAFILTRATION VERSUS HEMODIALYSIS IN END-STAGE KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
by: Maria Gabriela Guimarães, et al.
Published: (2024-04-01)

Blood group antigens visualisation on leukocytes
by: Grigorovich Kravchun Pavlo, et al.
Published: (2024-01-01)

WCN24-864 Alport Syndrome: genetic variants, phenotypes of kidney disease and association with End Stage Kidney Disease in a Uruguayan Cohort
by: Federico Yandian, et al.
Published: (2024-04-01)

WCN24-163 KIDNEY ALLOGRAFT PATHOLOGY DURING THE FIRST YEAR OF TRANSPLANT. THREE YEARS DATA FROM IRAQ
by: A.L.A. Ali, et al.
Published: (2024-04-01)

WCN24-747 CLINICAL CHARACTERISTICS AND PREDICTIVE MODEL FOR SEVERE CORONARY ARTERY CALCIFICATION IN END-STAGE KIDNEY DISEASE PATIENTS
by: Ningning Wang, et al.
Published: (2024-04-01)

WCN24-1265 THE SAFETY OF SYSTEMIC ANTICANCER TREATMENT IN PATIENTS WITH END-STAGE KIDNEY DISEASE AND METASTATIC RENAL CELL CARCINOMA
by: Tomaz Milanez, et al.
Published: (2024-04-01)

WCN24-391 Predictive Factors of Renal Recovery and Progression to End-Stage Kidney Disease in Patients with ANCA-Associated Vasculitis with Severe Kidney Disease
by: Marta Casal Moura, et al.
Published: (2024-04-01)

WCN24-973 RENAL DENERVATION IN PATIENTS WITH END-STAGE KIDNEY DISEASE, A NEW OPTION TO REDUCE CARDIOVASCULAR RELATED HOSPITALIZATIONS
by: Mauricio Gómez, et al.
Published: (2024-04-01)

WCN24-156 PLASMA MARINE N-3 POLYUNSATURATED FATTY ACIDS AND CORONARY ATHEROSCLEROSIS IN PATIENTS WITH END STAGE KIDNEY DISEASE
by: Bahram Hashemi Dam, et al.
Published: (2024-04-01)

WCN24-1631 TRANSFORMING KIDNEY CARE IN BRUNEI DARUSSALAM POST COVID-19: PROJECT ONE'S IMPACT ON LOCAL END-STAGE KIDNEY DISEASE MANAGEMENT
by: Chiao Yuen Lim, et al.
Published: (2024-04-01)

Human leukocyte antigen-A*24:02-B*40:247-C*03:04-DRB1*16:02, a deduced probable human leukocyte antigen haplotype associated with a low-incidence human leukocyte antigen allele B*40:247 in Taiwanese individuals: A case analysis
by: Kuo-Liang Yang, et al.
Published: (2018-01-01)

WCN24-2225 COMPARISON OF HANDHELD VERSUS HIGH-END ULTRASOUND DEVICES FOR THE GUIDANCE OF PERCUTANEOUS KIDNEY BIOPSY
by: Cristina Chediak, et al.
Published: (2024-04-01)

WCN24-863 HISTOPLASMA ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN KIDNEY TRANSPLANT RECIPIENT
by: Walaa Dabbas, et al.
Published: (2024-04-01)

WCN24-1073 EFFICACY OF TENAPANOR AS A PHOSPHATELOWERING THERAPY IN PATIENTS WITH END-STAGE KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
by: Maria Gabriela Guimarães, et al.
Published: (2024-04-01)

Imputing amino acid polymorphisms in human leukocyte antigens.
by: Xiaoming Jia, et al.
Published: (2013-01-01)

WCN24-2513 TRANSIENT ACUTE KIDNEY INJURY AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
by: María José Soler Romeo, et al.
Published: (2024-04-01)

Using high-resolution human leukocyte antigen typing of 11,423 randomized unrelated individuals to determine allelic varieties, deduce probable human leukocyte antigen haplotypes, and observe linkage disequilibria between human leukocyte antigen-B and-C and human leukocyte antigen-DRB1 and-DQB1 alleles in the Taiwanese Chinese population
by: Kuo-Liang Yang, et al.
Published: (2017-01-01)

Deduced probable human leukocyte antigen haplotypes associated with human leukocyte antigen DRB1*04:36 identified by case analysis of Taiwanese individuals
by: Kuo-Liang Yang, et al.
Published: (2017-01-01)

Increased thrombin generation in kidney transplant recipients with donor-specific antibodies directed against human leukocyte antigens
by: Linda Lóczi, et al.
Published: (2024-10-01)

WCN24-2585 Outcomes of commercial kidney transplantation: single center experience
by: Ali M. Shendi, et al.
Published: (2024-04-01)

WCN24-20 KIDNEY RE-TRANSPLANTATION IN CHILDREN
by: Mohamad Bassam Said
Published: (2024-04-01)

Human leukocyte antigen associations with acute leukemia: An indian perspective
by: Hina Solanki, et al.
Published: (2020-01-01)

Multiple sclerosis: disease modifying therapy and the human leukocyte antigen
by: Lineu Cesar Werneck, et al.

The Impact of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen-E, Human Leukocyte Antigen-G Polymorphisms on Innate Immunity and COVID-19 Severity
by: Cigdem Kekik, et al.
Published: (2025-01-01)

WCN25-3023 Upper Gastrointestinal Bleeding in End-Stage Chronic Kidney Disease
by: Luz Alcantar Vallin, et al.
Published: (2025-02-01)

WCN24-1268 End-Stage Kidney Disease (ESKD) and Chronic Kidney Disease (CKD) Progression among a Hispanic/Latino Population with Primary Immunoglobulin A Nephropathy (IgAN)
by: John Sim, et al.
Published: (2024-04-01)

WCN24-1701 MINIMAL CHANGE DISEASE FOLLOWING THE SECOND DOSE OF PFIZER-BIONTECH (BNT162B1) FOR SARS-COV-2. COINCIDENCE OR CAUSALITY?
by: Juan Carlos González García, et al.
Published: (2024-04-01)

WCN24-1074 INTRACRANIAL ANEURYSMS IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): A SAMPLE OF BRAZILIAN PATIENTS
by: Bruno Cerqueira, et al.
Published: (2024-04-01)

WCN24-2349 MUSCLE QUALITY IN CHRONIC KIDNEY DISEASE
by: F.E.R.N.A.N.D.O. MARGULIS, et al.
Published: (2024-04-01)

Human leukocyte antigen - HLA B*27: Unraveling the link to pathogenesis
by: Sakir Ahmed, et al.
Published: (2020-01-01)

WCN24-330 TRENDS OF PREEMPTIVE KIDNEY TRANSPLANTATION IN PATIENTS APPROACHING END-STAGE RENAL DISEASE STRATIFIED BY PRIMARY DISEASE IN THE UNITED STATES FROM 1985 AND 2019
by: Gabriel Nicolas Contreras Martin, et al.
Published: (2024-04-01)